<DOC>
	<DOCNO>NCT00745173</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics ( absorption , distribution , breakdown elimination body ) single dose bazedoxifene ( BZA ) 20 mg tablet administer together multiple dos Premarin ( conjugate estrogens CE ) healthy postmenopausal woman . Information also obtain regard safety tolerability combination healthy , postmenopausal woman .</brief_summary>
	<brief_title>Study Evaluating Premarin Bazedoxifene Potential Interaction</brief_title>
	<detailed_description />
	<mesh_term>Bazedoxifene</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<criteria>For inclusion study , woman must healthy postmenopausal ( either naturally surgically ) age 35 70 , inclusive . Blood hormone level must consistent postmenopausal state ( specified subject ) . They either nonsmoker smoke less 10 cigarette per day , able abstain smoking clinic confinement A subject exclude participation : Have participate clinical drug study within 30 day prior study medication administration ; Have history drug alcohol abuse within 1 year consume 2 standard unit per day alcohol ( standard unit equal 12 ounce beer , 1 Â½ ounce 80proof alcohol 6 ounce wine ) ; Donate plasma blood total study .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>